Millar Kerri-Ann
SEC CIK 1739126 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | CFO | 14.3K | — | $17.8K | 5 | 2021-08-23 | 2022-08-22 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Millar Kerri-Ann made no open-market trades at CUE in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-23 | 2022-08-21 | CUE | Cue Biopharma, Inc. | Millar Kerri-Ann | CFO | M - OptEx | — | +6,667 | 17.1K | +64% | — |
| D | 2022-08-23 | 2022-08-22 | CUE | Cue Biopharma, Inc. | Millar Kerri-Ann | CFO | F - Tax | $3.05 | -2,828 | 14.3K | -17% | -$8,625 |
| DM | 2021-10-05 | 2021-08-23+ | CUE | Cue Biopharma, Inc. | Millar Kerri-Ann | CFO | M - OptEx | $1.18 | +7,918 | 11.7K | +208% | +$9,382 |
| D | 2021-10-05 | 2021-08-23 | CUE | Cue Biopharma, Inc. | Millar Kerri-Ann | CFO | F - Tax | $0.00 | -1,961 | 10.5K | -16% | $0 |
| D | 2021-10-05 | 2021-10-01 | CUE | Cue Biopharma, Inc. | Millar Kerri-Ann | CFO | S - Sale+OE | $14.21 | -1,251 | 10.5K | -11% | -$17.8K |
Purchase Sale Sale after option exercise All abbreviations